Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage

https://doi.org/10.1016/S0014-2999(96)00593-6Get rights and content

Abstract

It has been previously demonstrated that selegiline, an irreversible monoamine oxidase B (MAO-B) inhibitor, potentiates glial reaction to injury and possesses some ‘trophic-like’ activities which do not depend on the inhibition of MAO-B and which are probably associated with the induction of astrocyte-derived neurotrophic substances. Based on these findings, we tried to find out whether selegiline is able to modify the expression of nerve growth factor (NGF) and to protect central nervous system (CNS) neurons from excitotoxic and ischemic damage. Selegiline (10 pM–1 nM) induced NGF messenger RNA (mRNA) expression in cultured rat cortical astrocytes as determined by reverse transcription-polymerase chain reaction (RT-PCR) followed by a corresponding increase in NGF protein content measured by two-site NGF-enzyme-linked immunosorbent assay (ELISA) in astrocyte-conditioned medium. Additionally, exposure of hippocampal cultures containing neuronal and glial cells to this drug at the same concentrations enhanced significantly the content of NGF measured in the culture medium after 6 h of incubation. We hypothesize that selegiline could rescue hippocampal neurons from injury by induction of astrocyte-derived NGF in this cell culture system. To test this hypothesis, an excitotoxic damage was induced in the same type of cells by exposure to 0.5 mM l-glutamate for 1 h. Selegiline (10 pM–1 nM) present in the growth medium 6 h before until 18 h after induction of injury (the point of glutamate-toxicity measurement) protected hippocampal neurons from excitotoxic death. Furthermore, administered intraperitoneally (i.p.) (8 × 15 mg/kg per day) this drug enhanced the expression of NGF message in intact rat cerebral cortex and protected rat cortical tissue from ischemic insult due to permanent occlusion of the middle cerebral artery (MCA). The neuroprotective activity of selegiline (5 × 10 mg/kg per day i.p.) was also demonstrated in a mouse model of focal cerebral ischemia. The present data show that selegiline induced NGF expression in cultured rat cortical astrocytes. In mixed primary cultures of hippocampal neuronal and glial cells, selegiline increased NGF protein content and protected hippocampal neurons from excitotoxic degeneration. In vivo, this drug induced NGF gene expression in cerebral cortex from intact rats and protected rat and mouse cortical tissue from ischemic insult after occlusion of the MCA. Our results indicate that the induction of astrocyte-derived NGF could contribute to the neuroprotective activity of selegiline demonstrated both in vivo and in vitro and can explain, in part, the ‘trophic-like’ properties of this compound which has been observed by others.

References (62)

  • J.T. Greenamyre et al.

    Excitatory amino acids and Alzheimer's disease

    Neurobiol. Aging

    (1989)
  • F. Hefti et al.

    Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyl-transferase activity in adult rats with partial septo-hippocampal lesions

    Brain Res.

    (1984)
  • Y. Iwasaki et al.

    Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons

    J. Neurol. Sci.

    (1994)
  • W.Y.H. Ju et al.

    (−)-Deprenyl alters the time course of death of axotomized facial motoneurons and the hypertrophy of neighboring astrocytes in immature rats

    Exp. Neurol.

    (1994)
  • E. Koutsilieri et al.

    Selegiline enhances survival and neurite outgrowth of MPP-treated dopaminergic neurons

    Eur. J. Pharmacol. Mol. Pharmacol. Sec.

    (1994)
  • H. Lorez et al.

    Nerve growth factor increases in adult rat brain after hypoxic injury

    Neurosci. Lett.

    (1989)
  • J.W. Olney et al.

    Excitotoxicity of l-DOPA and 6-OH-DOPA: implications for Parkinson's and Huntington's diseases

    Exp. Neurol.

    (1990)
  • C. Schmalenbach et al.

    Astroglia-neuron interactions that promote long-term neuronal survival

    J. Chem. Neuroanat.

    (1993)
  • M.V. Sofroniew et al.

    Neurotrophic mechanisms and neuronal degeneration

    Semin. Neurosci.

    (1993)
  • S. Stoll et al.

    Age-related memory decline and longevity under treatment with selegiline

    Life Sci.

    (1994)
  • S.R. Whittemore et al.

    The expression, localization and functional significance of β-nerve growth factor in the central nervous system

    Brain Res. Rev.

    (1987)
  • S. Yamamoto et al.

    Protective effect of NGF atelocollagen mini-pellet on hippocampal delayed neuronal death in gerbils

    Neurosci. Lett.

    (1992)
  • Y.C. Zeng et al.

    Effect of long-term treatment with l-deprenyl on the age-dependent microanatomical changes in the rat hippocampus

    Mech. Aging Dev.

    (1995)
  • K.S. Ansari et al.

    Rescue of axotomized immature rat-facial motoneurons by R(−)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition

    J. Neurosci.

    (1993)
  • C. Ayer-LeLievre et al.

    Expression of the β-nerve growth factor gene in hippocampal neurons

    Science

    (1988)
  • G. Biagini et al.

    l-Deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain

    NeuroReport

    (1993)
  • W. Birkmayer et al.

    Increased life expectancy resulting from addition of l-deprenyl to madopar treatment in Parkinson's disease: a long term study

    J. Neural. Transm.

    (1985)
  • F. Eclancher et al.

    Reactive astrogliosis after basic fibroblast growth factor (bFGF) injection in injured neonatal rat brain

    Glia

    (1990)
  • C.M. Gall et al.

    Limbic seizures increase neuronal production of messenger RNA for nerve growth factor

    Science

    (1989)
  • D. Giulian et al.

    Brain glia release factors with opposing actions upon neuronal survival

    J. Neurosci.

    (1993)
  • C. Grothe et al.

    Basic fibroblast growth factor in the hypoglossal system: specific retrograde transport, trophic and lesion-related responses

    J. Neurosci. Res.

    (1992)
  • Cited by (145)

    • Rationale for an experimental treatment of retinitis pigmentosa: 140-Month test of hypothesis with one patient

      2013, Medical Hypotheses
      Citation Excerpt :

      Trophic factor withdrawal is a widely recognized cause of neuron apoptosis. It is therefore important to note that deprenyl, in addition to inhibiting apoptosis, may also exert protective effects on cones by the upregulation of eight neurotrophic factors: basic fibroblast growth factor, bFGF [28]; nerve growth factor, NGF [29]; ciliary neurotrophic factor, CNTF [30]; glial cell line-derived neutrophic factor, GDNF [31]; brain-derived neurotrophic factor and GDNF [32]; insulin-like growthfactor-1, IGF-1 [33]; superoxide dismutase via NGF [34]; and fibroblast growthfactor-2, FGF-2, and bFGF [35]. The delivery of one of these trophic factors, CNTF by Neurotech’s encapsulated cell technology, is currently undergoing clinical trials for RP and age-related macular degeneration [36].

    View all citing articles on Scopus
    View full text